This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

Delhi HC orders forensic audit of Fortis, Singh brothers' Rs 4,666-crore trail

The Delhi High Court ordered a forensic audit of Fortis Healthcare transactions. This audit will examine dealings with IHH Healthcare Berhad and RHT Health Trust. It will also probe transactions involving the Singh brothers and Religare Group companies. The court seeks to trace the movement of shares and funds. This comprehensive audit must be completed within six months.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QbyhGro
via IFTTT

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of companies to twenty-six manufacturers. The deals cover medicines for chronic and rare diseases, benefiting Medicaid programs. Sun Pharma will contribute antibiotics to the US Strategic Active Pharmaceutical Ingredients Reserve. These initiatives aim to reduce reliance on foreign suppliers and lower costs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WK9DlJh
via IFTTT

Zydus’ Saroglitazar meets primary goal in global Phase II(b) MASH trial

Zydus Lifesciences said its drug Saroglitazar Magnesium met the primary goal of a global Phase II(b) trial for MASH, a serious liver disease linked to metabolic disorders.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/a6rsDj4
via IFTTT

India seeks easier pharma access in Brazil, pushes to expand Mercosur trade pact

India seeks predictable regulations and easier market access for its pharmaceutical products. Discussions occurred at the India-Brazil Trade Monitoring Mechanism meeting in Brasilia. Both nations aim to expand the existing India-Mercosur trade agreement soon. Bilateral trade between India and Brazil is targeted to reach thirty billion dollars. This move aims to deepen economic ties and expand India's Latin American market presence.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/61n5FEv
via IFTTT

Healthcare ranks second in private credit deals as domestic funds dominate in H1 2026: EY report

India’s private credit market deployed $3.5 billion across more than 100 deals in H1 2026, broadly unchanged from $3.4 billion in H2 2025, according to EY.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QVWef32
via IFTTT

Jharkhand on high alert over Swine Flu; Health Minister directs hospitals to reserve beds, ramp up surveillance

Jharkhand Health Department is on high alert for potential H1N1 cases. Health Minister Irfan Ansari directed enhanced surveillance and hospital preparedness across the state. Ten additional beds are reserved in all medical college and district hospitals. Monitoring of Influenza-Like Illness and Severe Acute Respiratory Infection cases is intensified. Health teams will screen individuals at major transit points for immediate care.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EIXoHG0
via IFTTT

Park Medi World to expand hospital network across north India, add 1,450 beds by FY28

Park Medi World plans to add 1,450 beds by FY28, expanding its northern India network. The hospital chain focuses on Tier 1, 2, and 3 cities for efficient scaling. Acquisitions will target hospitals with 200-250 beds, expandable to 350. The company reported record net profit and revenue in FY26. Park Medi World is also adopting cleaner energy systems across its facilities.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/M7wtTK1
via IFTTT